Analysis on Supply-side Structural Reform Strategy of Drug Distribution Based on Structure-conduct-per-formance Analysis Paradigm
10.6039/j.issn.1001-0408.2017.10.01
- VernacularTitle:基于结构-行为-绩效分析范式的药品流通领域供给侧结构性改革策略分析
- Author:
Fan LI
;
Boyang YU
;
Renyuan CAO
;
Yaru CAO
;
Liang HONG
- Keywords:
Structure-conduct-performance analysis;
Drug distribution;
Supply-side reform;
Industry structure upgrading
- From:
China Pharmacy
2017;28(10):1297-1301
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To provide basic industrial research and development recommendations for the supply-side structural reform in drug distribution in China. METHODS:Structure-conduct-performance(SCP)analysis paradigm from Harvard was used for in-depth study of market structure,business conduct and business performance in China since 2010. RESULTS:Since 2010, drug distribution industry in China had shown the scale of decline in the growth rate,low market concentration,increased barriers to entry,the leading of state-owned capital,etc. Though corporate mergers and acquisitions and public financing expanded the scale,management information,third-party logistics,Internet+and pharmacy alliance business model flourished,the industry op-erating performance was poor,state-owned enterprises showed poor performance. CONCLUSIONS:The transformation and upgrad-ing of the industry business model should be promoted by targetedly accelerating the supply-side structural reforms in the drug distri-bution industry,encouraging corporate finance mergers,breaking local protectionism,developing cooperative pharmacies and phar-maceutical third-party logistics alliances and leveraging the Internet.
